Brittany (France). Main data about clinical presentation and management were compared according to the gender. Results: Among 5000 patients included in the ORBI registry, 1174 patients (23.5%) were women (mean age: 68.8Ϯ14 vs 60.8Ϯ12 for men, pϽ0.0001), with significant differences in their cardiovascular risk factors, especially hypertension (54 vs 36%, pϽ0.0001), dylipidemia (44 vs 52%, pϽ0.0001) and current smoking (25 vs 51%, pϽ0.0001). As presented in table 1, there are some significant differences in the management of women: delays of reperfusion are longer, partially due to longer delays between symptom onset and call for medical assistance. Thrombolytic agents are less used in women, and coronary angiography is less performed. Moreover, morbi-mortality is higher in women: intra hospital women mortality is 9.0%, vs 4.4% for men (pϽ0.0001). Last, there is a significant underused in all of the recommend treatments at discharged. -delay between admission and reperfusion**
Conclusions:
Despite numerous awareness campaigns about management of STEMI in women, it still includes significant differences, resulting a higher morbidity and mortality.
TCT-361
Gender- Background: Everolimus-eluting stents (EES) improve safety compared with earlygeneration sirolimus-eluting (SES) and paclitaxel-eluting stents (PES). However, it is unknown whether the benefits in terms of safety are consistent among female and male patients. Methods: A total of 12,339 consecutive patients were treated at 2 academic institutions between 2002 and 2009. 11,954 patients -3,112 women (26%) and 8,842 men (74%) -completed last follow-up and were included in this analysis. EES were implanted among 1,100 women (35%) and 3,001 men (34%), whereas early-generation SES or PES were used among 2,012 women (65%) and 5,841 men (66%). We performed a stratified analysis of clinical outcomes between EES and early-generation SES or PES according to gender. Adjustment was performed with inverse probability of treatment weighting. Primary endpoint was ARC definite stent thrombosis (ST). Results: During follow to 4 years (median 2.9 years), the use of EES reduced the risk of definite ST to a similar extent in women (RR 0.41, ) and men (RR 0.40, ) compared with early-generation SES and PES. This was paralleled by a similar reduction in the risk of myocardial infarction with EES over early-generation SES and PES among women (RR 0.59, 95%CI 0.46-0.77) and men (RR 0.47, 95%CI 0.29-0.75; p-interactionϭ0.52), as well as the composite of cardiac death and myocardial infarction among women (RR 0.72, 95%CI 0.61-0.84) and men (RR 0.82, 95%CI 0.65-1.04; p-interactionϭ0.32). In addition, EES provided a comparable efficacy benefit in terms of target-vessel revascularization among women (RR 0.69, 95%CI 0.59-0.80) and men (RR 0.52, ) compared with early-generation SES and PES. Conclusions: Newer generation EES provide a similar safety benefit among women and men, with a consistent reduction in the risk of definite ST and myocardial infarction compared with early-generation SES and PES during long term follow-up.
TCT-362
Incidence, background, treatment strategies and the prognosis in very elderly patients with acute myocardial infarction -from Japanese multicenter database Takafumi Osaka National Hospital, Osaka, Japan Background: Aging society has changed the component of the population in world wide, especially Japanese is the most progressive. Therefore, classifying elderly patients, particularly those 75 years and older, as a single cluster may overlook differences in elderly patients. The aim of this study was to investigate how difference of clinical characteristics and outcomes of elderly hospitalized with acute myocardial infarction (AMI) vary based on age. Methods: We analyzed 3723 consecutive patients who enrolled as AMI from 27 hospitals during 2005 to 2009 in Japan. We categorized patients into four groups based on their age: younger than 65 years (nϭ1418), 65 to 74 years (nϭ1027), 75 to 84 years (nϭ935) and 85 years and older (nϭ343). Results: Older patients were more likely to be women and to have hypertension, renal insufficiency, less likely to have dyslipidemia, diabetes, smoking. Primary percutaneous coronary intervention (PCI) was performed at a high frequency in all groups (88.9% vs 86.3% vs 81.3% vs 73.8%: PϽ0.0001, respectively). In-hospital mortality rate rose gradually with age. (2.8 vs 6.4% vs 12.5% vs 19.8%:PϽ0.0001, respectively), and the same tendency can be seen whether they received primary PCI (2.6% vs 4.9% vs 9.6% vs 16.2%: PϽ0.0001, respectively) or not (3.8% vs 16.3% vs 25.1% vs 30.0%: PϽ0.0001, respectively). In multivariable analysis, age was one of the important predictor of in-hospital mortality. Conclusions: Despite high prevalence of primary-PCI in elderly in Japan, aging is strongly associated with in-hospital mortality.
TCT-363
Safety and long-term outcomes after percutaneous coronary interventions in patients with liver disease: report from the National Heart, Lung, and Blood Institute Dynamic Registry Northwestern University, Chicago, IL Background: Patients with liver disease who undergo percutaneous coronary interventions (PCI) have been thought to be at high risk of adverse events. The data regarding safety of PCI in patients with liver disease is sparse and there is no data on long-term outcomes post-PCI. Methods: Baseline demographic, procedure-related, and in-hospital and 1-year adverse outcome data on consecutive patients undergoing PCI during 5 recruitment ЉwavesЉ of the National Heart, Lung, and Blood Institute (NHLBI) Dynamic Registry across clinical centers which enrolled at least 1 patient with liver disease were collected. Patients with liver disease (nϭ79) were compared with patients without liver disease (nϭ5926). Results: Patients with liver disease were younger and represented more minorities in comparison to patients without liver disease undergoing PCI. They had significantly higher rates of renal and pulmonary disease and were more likely to be on insulin therapy, but had a similar prevalence of prior coronary artery disease history, myocardial infarction, heart failure and cardiac risk factors. Rates of multivessel disease, intervention success and anti-platelet therapy were not significantly different between groups. There was no increased incidence of peri-procedural complications including bleeding requiring transfusion (pϭ0.29), major entry site complications (pϭ0.70), and stroke (pϭ0.70). At 1 year, cumulative event rates, including death, myocardial infarction, coronary artery bypass graft surgery, and repeat PCI were similar between the groups (Table 1) . 
Background:
Various studies have shown that there may well be biological differences in men and women relative to the pathogenesis, clinical presentation, vessel involvement and management of cardiovascular disease (CVD) in developed countries. However, gender disparity in CVD is not adequately reported in developing countries like India. Hence, we assessed gender differences in terms of risk factors and treatment options for CVD in a large number of patients in Western India. Methods: Patients with CVD were enrolled in the study. Gender-based differences in age, habitat, risk factors, clinical presentation, angiography procedure approach and treatment options were analyzed. Subjects were categorized based on interventions like coronary artery bypass graft (CABG), percutaneous coronary intervention (PCI), and medical therapy respectively for analyzing treatment options. Results: A total of 26,971 consecutive patients were enrolled in the present study. Of these, 21,266 (78.85%) were males and 5,705 (21.15%) were females. Prevalence of CVD was higher in urban female subjects (pϽ0.0001) whereas it was higher in males in rural areas (pϽ0.0001). As compared to males, female population had an increased prevalence of hypertension (pϽ0.0001), diabetes (pϭ0.01) and family history (pϽ0.0001); while male population had smoking (pϽ0.0001) as a contributable risk factor. Obesity contributed equally as a risk factor to both male and female subjects. Number of patients who underwent angiography procedure was significantly higher in male population (pϽ0.0001) as compared to female population irrespective of radial or femoral approach. Treatment options like CABG (18.45% vs. 12.42%, pϽ0.0001) and PCI (45.04% vs. 40.73%, pϭ0.001) were higher in males as compared to female subjects where medical therapy was the preferred option (46.83% vs. 36.49%, pϽ0.0001) irrespective of the contributing/confounding factors. Conclusions: Gender related wide differences to testing, prevention and availed treatment options prevail in Indian CVD patients as noticed globally. This difference however is very significant and will need global and combined efforts to correct.
TCT-365
Pregnancy-Induced Disorders Identify High-Risk Women who Benefit from Cardiovascular Screening: Results from the Women's Heart Health Initiative, an OB/GYN Screening Pilot Program
